Is 3,17-Dimethyl-9-alpha,13-alpha,14-alpha-morphinan phosphate Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use 3,17-Dimethyl-9-alpha,13-alpha,14-alpha-morphinan phosphate? Is 3,17-Dimethyl-9-alpha,13-alpha,14-alpha-morphinan phosphate safe for nursing mother and child? Does 3,17-Dimethyl-9-alpha,13-alpha,14-alpha-morphinan phosphate extracts into breast milk? Does 3,17-Dimethyl-9-alpha,13-alpha,14-alpha-morphinan phosphate has any long term or short term side effects on infants? Can 3,17-Dimethyl-9-alpha,13-alpha,14-alpha-morphinan phosphate influence milk supply or can 3,17-Dimethyl-9-alpha,13-alpha,14-alpha-morphinan phosphate decrease milk supply in lactating mothers?
3,17-Dimethyl-9-alpha,13-alpha,14-alpha-morphinan phosphate lactation summary
- DrLact safety Score for 3,17-Dimethyl-9-alpha,13-alpha,14-alpha-morphinan phosphate is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of 3,17-Dimethyl-9-alpha,13-alpha,14-alpha-morphinan phosphate is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that 3,17-Dimethyl-9-alpha,13-alpha,14-alpha-morphinan phosphate does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of 3,17-Dimethyl-9-alpha,13-alpha,14-alpha-morphinan phosphate safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About 3,17-Dimethyl-9-alpha,13-alpha,14-alpha-morphinan phosphate usage in lactation
Centrally-acting non-narcotic antitussive, chemically related to codeine but devoid of central depressant effects (AEMPS 2014, Ida 1997).Chemically similar to dextromethorphan (Shin 2011).Administered orally 3 times a day.A product which has very few bibliographical references. Since the last update, we have not found published data on its excretion in breast milk. Its use is authorized in infants from 6 months of age. Given its lack of sedative effects, use at a sufficient minimum dose and for non-prolonged periods would have low risk during breastfeeding. As there is less published experience than with other drugs from the same group, safer known alternatives may be preferable during the neonatal period and in case of prematurity.
Alternate Drugs for Cough suppressants, Opium alkaloids and derivatives. ATC R05DA
Dextromethorphan(Safe)
Dimemorfan Phosphate(Safe)
Pholcodine(Low Risk)
Noscapine(Safe)
Folcodina(Low Risk)
Narcotine(Safe)